{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T12:54:32Z","timestamp":1783515272062,"version":"3.55.0"},"reference-count":130,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.cld.2016.06.001","type":"journal-article","created":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T04:11:24Z","timestamp":1471061484000},"page":"629-644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Evolution in Our Understanding of Hepatitis B Virus Virology and Immunology"],"prefix":"10.1016","volume":"20","author":[{"given":"Bertram","family":"Bengsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong-Mi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2016.06.001_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.26787","article-title":"The road not taken or how I learned to love the liver: a personal perspective on hepatitis history","volume":"59","author":"Alter","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.06.001_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1743-422X-10-239","article-title":"Medical virology of hepatitis B: how it began and where we are now","volume":"10","author":"Gerlich","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.cld.2016.06.001_bib3","doi-asserted-by":"crossref","first-page":"a021345","DOI":"10.1101\/cshperspect.a021345","article-title":"Viral hepatitis: past and future of HBV and HDV","volume":"5","author":"Thomas","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.cld.2016.06.001_bib4","first-page":"20","article-title":"Eine icterusepidemie","author":"Luerman","year":"1885","journal-title":"Ber Klin Wochenschr"},{"key":"10.1016\/j.cld.2016.06.001_bib5","first-page":"108","article-title":"Acute yellow atrophy","volume":"15","author":"McDonald","year":"1908","journal-title":"Edinb Med J"},{"key":"10.1016\/j.cld.2016.06.001_bib6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1056\/NEJM198704163161601","article-title":"A\u00a0serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army","volume":"316","author":"Seeff","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2016.06.001_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jramc-149-02-04","article-title":"The discovery of viral hepatitis: a military perspective","volume":"149","author":"Martin","year":"2003","journal-title":"J\u00a0R Army Med Corps"},{"key":"10.1016\/j.cld.2016.06.001_bib8","first-page":"691","article-title":"Homologous serum jaundice","volume":"2","author":"MacCallum","year":"1947","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2016.06.001_bib9","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.1967.03120180053006","article-title":"Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection","volume":"200","author":"Krugman","year":"1967","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1016\/j.cld.2016.06.001_bib10","first-page":"461","article-title":"Human volunteer and tissue culture studies of viral hepatitis","volume":"106","author":"Melnick","year":"1972","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.cld.2016.06.001_bib11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1001\/jama.1965.03080070025007","article-title":"A\u00a0\u201cnew\u201d antigen in leukemia sera","volume":"191","author":"Blumberg","year":"1965","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2016.06.001_bib12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.7326\/0003-4819-66-5-924","article-title":"A\u00a0serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis","volume":"66","author":"Blumberg","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2016.06.001_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1423-0410.1968.tb04078.x","article-title":"Observations on Australia antigen in Japanese","volume":"15","author":"Okochi","year":"1968","journal-title":"Vox Sang"},{"key":"10.1016\/j.cld.2016.06.001_bib14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1073\/pnas.60.3.814","article-title":"An antigen detected in the blood during the incubation period of serum hepatitis","volume":"60","author":"Prince","year":"1968","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"Suppl","key":"10.1016\/j.cld.2016.06.001_bib15","doi-asserted-by":"crossref","first-page":"S502","DOI":"10.1046\/j.1440-1746.17.s4.19.x","article-title":"The discovery of the hepatitis B virus and the invention of the vaccine: a scientific memoir","volume":"17","author":"Blumberg","year":"2002","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2016.06.001_bib16","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0140-6736(70)90926-8","article-title":"Virus-like particles in serum of patients with Australia-antigen-associated hepatitis","volume":"1","author":"Dane","year":"1970","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2016.06.001_bib17","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(71)90543-5","article-title":"New antigen-antibody system in Australia-antigen-positive hepatitis","volume":"2","author":"Almeida","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2016.06.001_bib18","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1128\/JVI.14.2.384-391.1974","article-title":"DNA of a human hepatitis B virus candidate","volume":"14","author":"Robinson","year":"1974","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cld.2016.06.001_bib19","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1128\/JVI.13.6.1231-1236.1974","article-title":"DNA polymerase in the core of the human hepatitis B virus candidate","volume":"13","author":"Robinson","year":"1974","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cld.2016.06.001_bib20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/299740a0","article-title":"Cloned HBV DNA causes hepatitis in chimpanzees","volume":"299","author":"Will","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.cld.2016.06.001_bib21","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0140-6736(81)90832-1","article-title":"Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2016.06.001_bib22","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/jama.1971.03190240019005","article-title":"Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulin","volume":"218","author":"Krugman","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2016.06.001_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/00000441-197509000-00025","article-title":"Purified and inactivated human hepatitis B vaccine: progress report","volume":"270","author":"Hilleman","year":"1975","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cld.2016.06.001_bib24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000441-197509000-00024","article-title":"Hepatitis B subunit vaccine: a preliminary report of safety and efficacy tests in chimpanzees","volume":"270","author":"Purcell","year":"1975","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cld.2016.06.001_bib25","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(76)93023-3","article-title":"Immunisation against hepatitis B in man","volume":"1","author":"Maupas","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2016.06.001_bib26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM198010093031501","article-title":"Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States","volume":"303","author":"Szmuness","year":"1980","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2016.06.001_bib27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/307178a0","article-title":"Human hepatitis B vaccine from recombinant yeast","volume":"307","author":"McAleer","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.cld.2016.06.001_bib28","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1001\/jama.1989.03420220092033","article-title":"Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers","volume":"261","author":"Poovorawan","year":"1989","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2016.06.001_bib29","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/jnci\/djp288","article-title":"Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study","volume":"101","author":"Chang","year":"2009","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cld.2016.06.001_bib30","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2893.2010.01312.x","article-title":"Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region","volume":"18","author":"Poovorawan","year":"2011","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cld.2016.06.001_bib31","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1073\/pnas.76.5.2222","article-title":"Cloning in Escherichia coli and physical structure of hepatitis B virion DNA","volume":"76","author":"Charnay","year":"1979","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.cld.2016.06.001_bib32","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/282575a0","article-title":"Hepatitis B virus genes and their expression in E. coli","volume":"282","author":"Pasek","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.cld.2016.06.001_bib33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/280815a0","article-title":"Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen","volume":"280","author":"Valenzuela","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.cld.2016.06.001_bib34","first-page":"335","article-title":"A\u00a0new antigen complex co-occurring with Australia antigen","volume":"80","author":"Magnius","year":"1972","journal-title":"Acta Pathol Microbiol Scand B Microbiol Immunol"},{"key":"10.1016\/j.cld.2016.06.001_bib35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0042-6822(88)90266-8","article-title":"Formation of transmembraneous hepatitis B e-antigen by cotranslational in\u00a0vitro processing of the viral precore protein","volume":"163","author":"Bruss","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.cld.2016.06.001_bib36","doi-asserted-by":"crossref","first-page":"8405","DOI":"10.1073\/pnas.85.22.8405","article-title":"A\u00a0signal peptide encoded within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens in Xenopus oocytes","volume":"85","author":"Standring","year":"1988","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.cld.2016.06.001_bib37","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1002\/hep.20956","article-title":"Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005","volume":"43","author":"Yim","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.06.001_bib38","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.patbio.2010.02.003","article-title":"A\u00a02010 update on occult hepatitis B infection","volume":"58","author":"Raimondo","year":"2010","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.cld.2016.06.001_bib39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/hep.24257","article-title":"Occult and previous hepatitis B virus infection are not associated with hepatocellular carcinoma in United States patients with chronic hepatitis C","volume":"54","author":"Lok","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.06.001_bib40","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1096-1104","article-title":"The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response","volume":"2","author":"Rehermann","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.cld.2016.06.001_bib41","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/infdis\/137.6.822","article-title":"Prevalence of hepatitis B virus infection and hepatocellular carcinoma in Chinese-Americans","volume":"137","author":"Szmuness","year":"1978","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cld.2016.06.001_bib42","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2016.06.001_bib43","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/j.1460-2075.1990.tb08220.x","article-title":"Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA","volume":"9","author":"Hohne","year":"1990","journal-title":"EMBO J"},{"key":"10.1016\/j.cld.2016.06.001_bib44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/343457a0","article-title":"The preS2\/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator","volume":"343","author":"Kekule","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.cld.2016.06.001_bib45","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.06.001_bib46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ccr.2014.01.030","article-title":"Viral-human chimeric transcript predisposes risk to liver cancer development and progression","volume":"25","author":"Lau","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cld.2016.06.001_bib47","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jhep.2015.09.013","article-title":"Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122","volume":"64","author":"Liang","year":"2016","journal-title":"J\u00a0Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2016.06.001_bib48","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM197609022951001","article-title":"Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis","volume":"295","author":"Greenberg","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cld.2016.06.001_bib49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.gastro.2015.09.043","article-title":"Combination of tenofovir disoproxil fumarate and peginterferon alpha-2a increases loss of hepatitis B surface antigen in patients with chronic hepatitis B","volume":"150","author":"Marcellin","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib50","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0092-8674(80)90443-2","article-title":"Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand","volume":"21","author":"Gerlich","year":"1980","journal-title":"Cell"},{"key":"10.1016\/j.cld.2016.06.001_bib51","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0092-8674(82)90157-X","article-title":"Replication of the genome of a hepatitis B\u2013like virus by reverse transcription of an RNA intermediate","volume":"29","author":"Summers","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.cld.2016.06.001_bib52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.virusres.2007.12.024","article-title":"Hepatitis B viruses: reverse transcription a different way","volume":"134","author":"Nassal","year":"2008","journal-title":"Virus Res"},{"key":"10.1016\/j.cld.2016.06.001_bib53","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(95)90388-7","article-title":"Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients","volume":"345","author":"Benhamou","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2016.06.001_bib54","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM199512213332501","article-title":"A\u00a0preliminary trial of lamivudine for chronic hepatitis B infection","volume":"333","author":"Dienstag","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2016.06.001_bib55","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1478-3231.2010.02399.x","article-title":"Hepatitis B virus resistance to antiviral drugs: where are we going?","volume":"31","author":"Zoulim","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2016.06.001_bib56","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.06.001_bib57","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.cld.2016.06.001_bib58","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jhep.2012.12.008","article-title":"The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus","volume":"58","author":"Volz","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.06.001_bib59","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3390\/ijms15022892","article-title":"NTCP and beyond: opening the door to unveil hepatitis B virus entry","volume":"15","author":"Watashi","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cld.2016.06.001_bib60","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib61","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.26982","article-title":"Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)","volume":"59","author":"Watashi","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.06.001_bib62","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1038\/mtna.2014.38","article-title":"The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates in\u00a0vivo","volume":"3","author":"Lin","year":"2014","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.cld.2016.06.001_bib63","doi-asserted-by":"crossref","first-page":"13734","DOI":"10.1038\/srep13734","article-title":"CRISPR\/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X","volume":"5","author":"Karimova","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.cld.2016.06.001_bib64","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2014.12.001","article-title":"Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR\/Cas RNA-guided DNA endonuclease","volume":"476","author":"Kennedy","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.cld.2016.06.001_bib65","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.cld.2016.06.001_bib66","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1126\/science.1092066","article-title":"Inhibition of hepatitis B virus replication by APOBEC3G","volume":"303","author":"Turelli","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.cld.2016.06.001_bib67","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/hep.20801","article-title":"APOBEC-mediated interference with hepadnavirus production","volume":"42","author":"Rosler","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.06.001_bib68","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/hep.21733","article-title":"Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C","volume":"46","author":"Baumert","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.06.001_bib69","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.cld.2016.06.001_bib70","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","article-title":"Stealth and cunning: hepatitis B and hepatitis C viruses","volume":"79","author":"Wieland","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cld.2016.06.001_bib71","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.cld.2016.06.001_bib72","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis B virus infection","volume":"137","author":"Dunn","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1365-2893.1998.00098.x","article-title":"Predictive value of aminotransferase and hepatitis B virus DNA levels on response to interferon therapy for chronic hepatitis B","volume":"5","author":"Lok","year":"1998","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cld.2016.06.001_bib74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Immunobiology and pathogenesis of viral hepatitis","volume":"1","author":"Guidotti","year":"2006","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.cld.2016.06.001_bib75","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/gut.2008.163600","article-title":"Early kinetics of innate and adaptive immune responses during hepatitis B virus infection","volume":"58","author":"Fisicaro","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.cld.2016.06.001_bib76","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.23226","article-title":"Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection","volume":"50","author":"Hosel","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.06.001_bib77","doi-asserted-by":"crossref","first-page":"8579","DOI":"10.1128\/JVI.01022-08","article-title":"Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus","volume":"82","author":"Guy","year":"2008","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cld.2016.06.001_bib78","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1053\/j.gastro.2009.05.047","article-title":"Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections","volume":"137","author":"Oliviero","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib79","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3389\/fimmu.2012.00351","article-title":"Natural killer cell functional dichotomy: a feature of chronic viral hepatitis?","volume":"3","author":"Mondelli","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.cld.2016.06.001_bib80","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T\u00a0cells susceptible to NK cell-mediated deletion","volume":"210","author":"Peppa","year":"2013","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cld.2016.06.001_bib81","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nm1780","article-title":"Aggravation of viral hepatitis by platelet-derived serotonin","volume":"14","author":"Lang","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.cld.2016.06.001_bib82","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.cell.2015.03.005","article-title":"Immunosurveillance of the liver by intravascular effector CD8(+) T\u00a0cells","volume":"161","author":"Guidotti","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cld.2016.06.001_bib83","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1053\/j.gastro.2012.08.046","article-title":"Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection","volume":"143","author":"Martinet","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib84","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/hep.25879","article-title":"Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection","volume":"56","author":"Martinet","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.06.001_bib85","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1084\/jem.20061287","article-title":"Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage","volume":"204","author":"Dunn","year":"2007","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cld.2016.06.001_bib86","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nm.3856","article-title":"Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells","volume":"21","author":"Pallett","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.cld.2016.06.001_bib87","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.4254\/wjh.v7.i21.2344","article-title":"Hepatitis B virus reactivation with a rituximab-containing regimen","volume":"7","author":"Tsutsumi","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.cld.2016.06.001_bib88","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.cld.2016.06.001_bib89","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.4049\/jimmunol.1103139","article-title":"IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection","volume":"189","author":"Das","year":"2012","journal-title":"J\u00a0Immunol"},{"issue":"6","key":"10.1016\/j.cld.2016.06.001_bib90","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0016-5085(77)80010-3","article-title":"Identification of lymphocytes in percutaneous liver biopsy cores. Different T: B cell ratio in HB sAg-positive and -negative hepatitis","volume":"72","author":"Miller","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib91","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","article-title":"Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection","volume":"145","author":"Ferrari","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cld.2016.06.001_bib92","doi-asserted-by":"crossref","first-page":"10445","DOI":"10.1073\/pnas.88.23.10445","article-title":"HLA class I-restricted human cytotoxic T\u00a0cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen","volume":"88","author":"Bertoletti","year":"1991","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.cld.2016.06.001_bib93","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/hep.1840130405","article-title":"Immune response of peripheral blood mononuclear cells to HBx-antigen of hepatitis B virus","volume":"13","author":"Jung","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.06.001_bib94","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.174.6.1565","article-title":"Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen","volume":"174","author":"Penna","year":"1991","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cld.2016.06.001_bib95","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1084\/jem.177.3.751","article-title":"HLA-A31- and HLA-Aw68-restricted cytotoxic T\u00a0cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis","volume":"177","author":"Missale","year":"1993","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cld.2016.06.001_bib96","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0016-5085(99)70289-1","article-title":"Direct ex\u00a0vivo analysis of hepatitis B virus-specific CD8(+) T\u00a0cells associated with the control of infection","volume":"117","author":"Maini","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib97","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T\u00a0cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cld.2016.06.001_bib98","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-gamma and tumor necrosis factor-alpha produced by T\u00a0cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","author":"Xia","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib99","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cld.2016.06.001_bib100","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1128\/JVI.80.7.3532-3540.2006","article-title":"Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T\u00a0cells identifies functionally and phenotypically defined memory T\u00a0cells during acute resolving hepatitis B virus infection","volume":"80","author":"Boettler","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cld.2016.06.001_bib101","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","author":"Maini","year":"2000","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cld.2016.06.001_bib102","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1053\/j.gastro.2008.03.037","article-title":"Dynamic programmed death 1 expression by virus-specific CD8 T\u00a0cells correlates with the outcome of acute hepatitis B","volume":"134","author":"Zhang","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib103","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1084\/jem.20131333","article-title":"Dysfunctional CD8+ T\u00a0cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction","volume":"211","author":"Kurktschiev","year":"2014","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cld.2016.06.001_bib104","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cld.2016.06.001_bib105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","article-title":"Overcoming T\u00a0cell exhaustion in infection and cancer","volume":"36","author":"Pauken","year":"2015","journal-title":"Trends Immunol"},{"key":"10.1016\/j.cld.2016.06.001_bib106","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","article-title":"Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B","volume":"138","author":"Fisicaro","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib107","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1053\/j.gastro.2012.08.041","article-title":"Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T\u00a0cells against HBV, but not HCV","volume":"143","author":"Fisicaro","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib108","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.24249","article-title":"Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T\u00a0cells in persistent hepatitis B virus infection","volume":"53","author":"Schurich","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.06.001_bib109","doi-asserted-by":"crossref","first-page":"e47648","DOI":"10.1371\/journal.pone.0047648","article-title":"Upregulation of the Tim-3\/galectin-9 pathway of T\u00a0cell exhaustion in chronic hepatitis B virus infection","volume":"7","author":"Nebbia","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2016.06.001_bib110","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s00535-013-0762-9","article-title":"B\u00a0and T lymphocyte attenuator is highly expressed on intrahepatic T\u00a0cells during chronic HBV infection and regulates their function","volume":"48","author":"Cai","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.cld.2016.06.001_bib111","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jhep.2014.07.005","article-title":"Restoration of HBV-specific CD8+ T\u00a0cell function by PD-1 blockade in inactive carrier patients is linked to T\u00a0cell differentiation","volume":"61","author":"Bengsch","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2016.06.001_bib112","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1053\/j.gastro.2013.12.036","article-title":"Hepatic immune regulation and its involvement in viral hepatitis infection","volume":"146","author":"Knolle","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib113","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.20022235","article-title":"PD-1 inhibits antiviral immunity at the effector phase in the liver","volume":"198","author":"Iwai","year":"2003","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cld.2016.06.001_bib114","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.18_suppl.lba101","article-title":"Phase I\/II safety and antitumor activity of nivolumab in patients with advanced hepatocellular carcinoma (HCC): CA209-040","volume":"33","author":"El-Khoueiry","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cld.2016.06.001_bib115","doi-asserted-by":"crossref","first-page":"e105703","DOI":"10.1371\/journal.pone.0105703","article-title":"Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules","volume":"9","author":"Raziorrouh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cld.2016.06.001_bib116","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/j.gastro.2015.11.050","article-title":"Hepatitis B virus-specific and global T-cell dysfunction in chronic hepatitis B","volume":"150","author":"Park","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib117","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/JVI.79.6.3322-3328.2005","article-title":"Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T\u00a0cells in patients with hepatitis B virus infection","volume":"79","author":"Franzese","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cld.2016.06.001_bib118","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI33402","article-title":"Bim-mediated deletion of antigen-specific CD8 T\u00a0cells in patients unable to control HBV infection","volume":"118","author":"Lopes","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2016.06.001_bib119","doi-asserted-by":"crossref","first-page":"e1003208","DOI":"10.1371\/journal.ppat.1003208","article-title":"The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T\u00a0cells","volume":"9","author":"Schurich","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.cld.2016.06.001_bib120","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1084\/jem.20072076","article-title":"Functional skewing of the global CD8 T\u00a0cell population in chronic hepatitis B virus infection","volume":"205","author":"Das","year":"2008","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cld.2016.06.001_bib121","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.gastro.2012.03.041","article-title":"Increased levels of arginase in patients with acute hepatitis B suppress antiviral T\u00a0cells","volume":"143","author":"Sandalova","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2016.06.001_bib122","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1172\/JCI118191","article-title":"Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection","volume":"96","author":"Rehermann","year":"1995","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2016.06.001_bib123","doi-asserted-by":"crossref","first-page":"575","DOI":"10.7326\/0003-4819-96-5-575","article-title":"Hepatitis B vaccine administered to chronic carriers of hepatitis b surface antigen","volume":"96","author":"Dienstag","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2016.06.001_bib124","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.28025","article-title":"Present and future therapies of hepatitis B: from discovery to cure","volume":"62","author":"Liang","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.06.001_bib125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.510300208","article-title":"A\u00a0pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899\u00a0T Cell Vaccine Study Group","volume":"30","author":"Heathcote","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2016.06.001_bib126","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/sj.gt.3302751","article-title":"Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study","volume":"13","author":"Yang","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.cld.2016.06.001_bib127","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/liv.12530","article-title":"Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice","volume":"35","author":"Yoon","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2016.06.001_bib128","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1172\/JCI66043","article-title":"Mobilizing monocytes to cross-present circulating viral antigen in chronic infection","volume":"123","author":"Gehring","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cld.2016.06.001_bib129","doi-asserted-by":"crossref","first-page":"20140374","DOI":"10.1098\/rstb.2014.0374","article-title":"T\u00a0cell engineering as therapy for cancer and HIV: our synthetic future","volume":"370","author":"June","year":"2015","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.cld.2016.06.001_bib130","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2013.04.047","article-title":"T\u00a0cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice","volume":"145","author":"Krebs","year":"2013","journal-title":"Gastroenterology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116300460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326116300460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T17:22:20Z","timestamp":1692465740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326116300460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":130,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1089326116300460"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2016.06.001","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution in Our Understanding of Hepatitis B Virus Virology and Immunology","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2016.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}